Overall, the in vitro and in vivo experimental results of this study consistently demonstrate that brianolide, a compound isolated from the soft coral Briareum stechei, effectively inhibits atopic dermatitis-related inflammation by regulating the MAPK and NF-κB signaling pathways. This evidence concerns the gene NFKB1 and atopic eczema.